These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7003799)

  • 21. Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.
    Russo G; Gast A; Schlaeger EJ; Angiolillo A; Pietropaolo C
    Protein Expr Purif; 1997 Jul; 10(2):214-25. PubMed ID: 9226718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin.
    Stevens WK; Nesheim ME
    Biochemistry; 1993 Mar; 32(11):2787-94. PubMed ID: 8457546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin.
    Billy D; Speijer H; Lindhout T; Hemker HC; Willems GM
    Biochemistry; 1995 Oct; 34(41):13699-704. PubMed ID: 7577961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromogenic assay for the prothrombin activator ecarin from the venom of the saw-scaled viper (Echis carinatus).
    Stocker K; Fischer H; Brogli M
    Toxicon; 1986; 24(1):81-9. PubMed ID: 3082039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecarin-mediated release of fibrinopeptides in human plasma.
    Dyr JE; Blombäck B; Kornalík F
    Thromb Res; 1983 Apr; 30(2):179-82. PubMed ID: 6346576
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.
    Callas DD; Fareed J
    Thromb Res; 1996 Sep; 83(6):463-8. PubMed ID: 8885140
    [No Abstract]   [Full Text] [Related]  

  • 27. Prothrombin Brussels, a new congenital defective protein.
    Kahn MJ; Govaerts A
    Thromb Res; 1974 Aug; 5(2):141-56. PubMed ID: 4415355
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator.
    Hofmann H; Bon C
    Biochemistry; 1987 Feb; 26(3):772-80. PubMed ID: 3552031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The action of prothrombin activated by Ecarin on fibrinogen.
    Dyr JE; Blombäck B; Kornalík F
    Thromb Res; 1983 May; 30(3):225-34. PubMed ID: 6346578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Snake venom proteases that activate blood-coagulation factor V.
    Kisiel W; Canfield WM
    Methods Enzymol; 1981; 80 Pt C():275-85. PubMed ID: 7043192
    [No Abstract]   [Full Text] [Related]  

  • 31. On the quantification of prothrombin from different species using Echis carinatus as activator.
    Tollersrud OK; Helgeland L
    Thromb Res; 1986 Jun; 42(6):737-47. PubMed ID: 3523815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction of human thrombin I fragment, prethrombin I, and alpha-thrombin with tissue thromboplastin].
    Timerbaev VN; Zubairov DM; Kiselev SV; Kirshin SV; Soboleva IV
    Biokhimiia; 1992 Jan; 57(1):77-90. PubMed ID: 1391207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin converting-and fibrinolytic effects of ecarin.
    Kornalík F
    Czech Med; 1985; 8(1):51-4. PubMed ID: 3922719
    [No Abstract]   [Full Text] [Related]  

  • 34. Exosites determine macromolecular substrate recognition by prothrombinase.
    Krishnaswamy S; Betz A
    Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activation of the anticlotting system by perfusion of the carotid sinus with prethrombin 1 in rabbits].
    Strukova SM; Mitroshina TN; Umarova BA; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1981 Dec; 67(12):1823-7. PubMed ID: 7333375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: analysis by analytical ultracentrifugation.
    Luckow EA; Lyons DA; Ridgeway TM; Esmon CT; Laue TM
    Biochemistry; 1989 Mar; 28(5):2348-54. PubMed ID: 2719956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the generation of thrombin and factor Xa by a fucoidan from the brown seaweed Ecklonia kurome.
    Nishino T; Fukuda A; Nagumo T; Fujihara M; Kaji E
    Thromb Res; 1999 Oct; 96(1):37-49. PubMed ID: 10554083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin.
    Nowak G; Bucha E
    Thromb Res; 1995 Nov; 80(4):317-25. PubMed ID: 8585044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of multisquamase, the prothrombin activator present in Echis multisquamatus venom.
    Petrovan RJ; Govers-Riemslag JW; Nowak G; Hemker HC; Rosing J; Tans G
    Thromb Res; 1997 Nov; 88(3):309-16. PubMed ID: 9526951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of prothrombin Barcelona. Evidence for active high molecular weight intermediates.
    Rabiet MJ; Elion J; Benarous R; Labie D; Josso F
    Biochim Biophys Acta; 1979 Apr; 584(1):66-75. PubMed ID: 444582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.